Skip to main content

Market Overview

55 Stocks Moving In Monday's Mid-Day Session



  • Limited (NYSE: WBAI) shares climbed 125.7% to $6.07 after the company announced a $23 million investment from Good Luck Information Technology. The company appointed Mr. Xianfeng Yang as CEO and Mr. Bo Yu as COO.
  • EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) gained 73.7% to $6.20 after the company announced the acquisition of privately-held Panoptes Pharma, which is developing a small molecule for the treatment of severe eye diseases with a high unmet medical need.
  • Nuverra Environmental Solutions, Inc. (NYSE: NES) shares climbed 60.9% to $3.7650 after the company’s board approved the adoption of a limited duration stockholder rights plan.
  • Editas Medicine, Inc. (NASDAQ: EDIT) gained 43.3% to $92.25. Editas Medicine, last week, named Meeta Chatterjee, Ph.D., to its Board of Directors.
  • Anterix Inc. (NASDAQ: ATEX) surged 31.5% to $38.76 after the company reported its first long-term 900 MHz broadband spectrum lease agreements, covering Ameren’s service territories for 30 years.
  • China Customer Relations Centers, Inc. (NASDAQ: CCRC) jumped 30.4% to $6.46 as the company reported a rise in earnings and sales for the first half of the year.
  • Nantkwest Inc (NASDAQ: NK) shares climbed 30.2% to $13.35. ImmunityBio and NantKwest agreed to Merge, creating a leading immunotherapy and cell therapy company.
  • RealPage, Inc. (NASDAQ: RP) gained 29.4% to $87.75 after the company announced it would be acquired for $88.75 per share in cash.
  • Liminal BioSciences Inc. (NASDAQ: LMNL) rose 26.6% to $5.18 after Piper Sandler initiated coverage on the stock with an Overweight rating and announced a $22 price target.
  • CuriosityStream Inc. (NASDAQ: CURI) shares surged 26.2% to $13.29.
  • AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) jumped 23.4% to $5.01 after climbing over 25% on Friday.
  • Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares gained 22.5% to $40.69 after the company agreed to sell its oncology business for up to $2 billion.
  • Pivotal Investment Corporation II (NYSE: PIC) jumped 22.5% to $18.77.
  • Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD) rose 22.2% to $51.38 after Lockheed Martin Corporation (NYSE: LMT) announced plans to acquire the company in a $5 billion deal.
  • Humanigen, Inc. (NASDAQ: HGEN) gained 21.8% to $18.90 after surging over 10% on Friday. Humanigen, last week, reported completion of enrollment in Phase 1 study of Ifabotuzumab in Glioblastoma Multiforme.
  • MINISO Group Holding Limited (NYSE: MNSO) rose 20% to $28.70. MINISO Group, on Friday, reported financial results for the first fiscal quarter ended September 30, 2020.
  • Silvergate Capital Corporation (NYSE: SI) surged 19.7% to $61.30.
  • fuboTV Inc. (NYSE: FUBO) gained 19% to $46.69.
  • SolarWinds Corporation (NYSE: SWI) shares jumped 17.8% to $16.70 after declining 19% on Friday amid hacking of the company's software.
  • SG Blocks, Inc. (NASDAQ: SGBX) shares climbed 16.7% to $5.31 after climbing around 13% on Friday. SG Blocks, last week, said its sees FY21 gross revenue of $20 million.
  • Vision Marine Technologies Inc. (NASDAQ: VMAR) gained 16.7% to $15.33.
  • Luminar Technologies Inc (NASDAQ: LAZR) jumped 16.3% to $32.14.
  • Marathon Patent Group, Inc. (NASDAQ: MARA) gained 16.3% to $10.87.
  • Organovo Holdings, Inc. (NASDAQ: ONVO) rose 16% to $11.93 after climbing 29% on Friday..
  • Intellia Therapeutics, Inc. (NASDAQ: NTLA) surged 15% to $63.82. SVB Leerink reiterated Intellia Therapeutics with an Outperform and raised the price target from $27 to $61..
  •, Inc. (NYSE: AI) gained 14.6% to $157.71 after surging 17% on Friday.
  • Elevate Credit, Inc. (NYSE: ELVT) shares rose 14.4% to $3.65.
  • Triterras Inc (NASDAQ: TRIT) gained 14.1% to $9.64 after the company said its CEO would buy shares of the stock.
  • Fuel Tech, Inc. (NASDAQ: FTEK) rose 13.2% to $3.60 after dropping 21% on Friday.
  • 908 Devices Inc. (NASDAQ: MASS) rose 13.2% to $55.49. 908 Devices shares surged 145% on Friday after the company priced its IPO at $20 per share..
  • Venus Concept Inc. (NASDAQ: VERO) rose 12.2% to $2.4288 after Madryn Asset Management disclosed a 20.3% stake in the company.
  • AIM ImmunoTech Inc (NYSE: AIM) surged 10.5% to $2.11 after the company’s drug Ampligen was awarded FDA's orphan drug designation status for the treatment of pancreatic cancer.
  • Tattooed Chef, Inc. (NASDAQ: TTCF) rose 9.3% to $24.22 after gaining 9% on Friday. Tattooed Chef, earlier during the month, reported the expansion of its product range with meat alternatives.
  • Clovis Oncology Inc (NASDAQ: CLVS) climbed 9% to $5.34 after the company's phase 3 trial for a cancer treatment met its primary endpoint.


Check out these big penny stock gainers and losers


  • MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares dipped 22.4% to $8.72 after dipping over 35% on Friday.
  • Wunong Net Technology Company Limited (NASDAQ: WNW) fell 26.3% to $57.50 after declining 36% on Friday. The company, last week, priced its IPO at $5 per share.
  • FG Financial Group, Inc. (NASDAQ: FGF) dropped 20.9% to $3.70 after climbing 51% on Friday.
  • Scopus BioPharma Inc. (NASDAQ: SCPS) fell 19.7% to $17.31 after declining over 36% on Friday. Scopus Biopharma, last week, priced its IPO at $5.5 per share.
  • GTT Communications, Inc. (NYSE: GTT) dropped 16.2% to $3.61.
  • uniQure N.V.. (NASDAQ: QURE) fell 16.1% to $38.54 after the gene therapy company announced a setback to its clinical study. uniQure said the FDA has placed its Hemophilia B gene therapy program, including the late-stage HOPE-B study, on clinical hold.
  • Optical Cable Corporation (NASDAQ: OCC) dropped 14.5% to $2.52 after the company posted a loss for its fourth quarter.
  • FibroGen, Inc. (NASDAQ: FGEN) shares declined 14.1% to $37.76. FibroGen, on Dec. 18, disclosed that the FDA has extended review period of new drug application for roxadustat for the treatment of anemia of chronic kidney disease by three months.
  • Takung Art Co., Ltd. (NYSE: TKAT) dropped 14% to $1.9680.
  • Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares declined 13.6% to $3.75.
  • CURO Group Holdings Corp. (NYSE: CURO) fell 12.9% to $14.44 after surging over 88% on Friday.
  • Scorpio Bulkers Inc. (NYSE: SALT) shares declined 12.7% to $15.04 as the company agreed to sell its remaining dry bulk vessels and exit the dry bulk sector during 2021.
  • Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares dropped 12% to $43.63.
  • Chinook Therapeutics, Inc. (NASDAQ: KDNY) fell 11.2% to $16.93.
  • Steelcase Inc. (NYSE: SCS) shares declined 9.5% to $12.31. Steelcase, last week, reported worse-than-expected Q3 results.
  • DBV Technologies S.A. (NASDAQ: DBVT) fell 7.6% to $2.78 after gaining over 5% on Friday.
  • Mereo BioPharma Group plc (NASDAQ: MREO) fell 7.2% to $3.34. Mereo BioPharma Group shares surged 63% on Friday after the company and Ultragenyx announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
  • Callon Petroleum Company (NYSE: CPE) fell 6.7% to $13.07 amid decline in oil prices.
  • QEP Resources Inc (NYSE: QEP) shares fell 6.5% to $2.16 after Diamondback Energy announced plans to acquire the company in an all-stock transaction.
  • BEST Inc. (NYSE: BEST) fell 5.8% to $2.44 after jumping over 26% on Friday.
  • Tesla Inc (NASDAQ: TSLA) fell 5.4% to $657.20. The stock has been added to the S&P 500 today. Fears over a new coronavirus strain spreading through Europe could also be weighing the stock down.

Related Articles (AI + AGIO)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at